Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

Kostner, GM.
Lipoprotein metabolism and atherogenesis: implications for therapy.
Cardiology. 1991; 78(3):194-201 Doi: 10.1159/000174786
Web of Science PubMed FullText FullText_MUG Google Scholar

Führende Autor*innen der Med Uni Graz: Kostner Gerhard
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: The causes of atherosclerosis are numerous, but disturbances in lipid and lipoprotein (LP) metabolism undoubtedly play a key role. Although there exist multiple forms of genetic and secondary hyperlipoproteinemias linked with premature vascular diseases there are only a few LP that need to be considered: low-density LP, beta-very-low-density LP, chylomicron remnants and LP(a). In addition, low HDL levels have been found to represent an independent risk factor. Prolonged residence times of these LP lead to chemical modification and interaction with platelets, smooth muscle cells, endothelial cells and macrophages. Atherogenesis is thus a concerted action. Knowledge of the metabolic pathways of most of these LP is necessary in order to be able to specifically influence hyperlipoproteinemia with dietary measures or, ultimately, with lipid-lowering drugs.
Find related publications in this database (using NLM MeSH Indexing): Antilipemic Agents - therapeutic use; Arteriosclerosis - etiology; Humans - etiology; Hyperlipoproteinemias - complications; Lipoproteins - metabolism; Receptors, Cell Surface - metabolism; Receptors, Lipoprotein - metabolism
Find related publications in this database (Keywords): Hyperlipoproteinemia; Lipoproteins; Apolipoproteins; Cholesterol; Lipoprotein Metabolism